As secretary of the HHS, Kennedy would oversee major health agencies, including the Food and Drug Administration (FDA), the ...
The official purpose of Robert F. Kennedy, Jr.'s marathon Senate confirmation hearings this week was for lawmakers to decide if Kennedy is fit to oversee 80,000 employees and a $1.8 trillion annual ...
In a pair of January confirmation hearings, senators considered President Donald Trump's nomination of Robert F. Kennedy Jr. for secretary of Health and Human Services.
Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of ...
Vermont Senators Bernie Sanders and Peter Welch, along with New Hampshire Sen. Maggie Hassan, were among lawmakers Wednesday from both parties grilling Robert F. Kennedy Jr., President Trump’s pick ...
Robert Kennedy Jr’s stance on abortion has shifted in recent years, aligning him more closely with President Trump's.
Cigna To Reform Prior Authorization, Provider Services In 2025 The Cigna Group will spend up to $150 million to reform its prior authorization, patient advocacy and provider services this year, CEO ...
Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as ...
In one of its last actions, the Biden administration released the next 15 drugs selected for Medicare negotiation and the blockbuster diabetes drug Ozempic will be among those bargained for this year.
Their prices have brought congressional scrutiny. Sales to Medicare, the US health program for seniors, account for about 10% of Novo’s annual revenue, according to an analysis by Leerink Partners.
Together, those 25 drugs account for a third of Medicare spending on prescriptions, Becerra said. Ozempic and Wegovy, in particular, have been scrutinized for their high out-of-pocket costs ...
Fifteen new drugs including the Ozempic will be included in Medicare's next round of price negotiation with drug makers, the Biden administration announced Friday. Ozempic, used to treat Type 2 ...